Emerald Bioscience to Present at the KCSA Cannabis Investor Conference
05. Januar 2021 08:30 ET
|
Emerald Bioscience, Inc.
San Diego, Calif, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a biopharmaceutical company focused on developing differentiated, proprietary...
Emerald Bioscience Provides Corporate Update
30. September 2020 08:30 ET
|
Emerald Bioscience, Inc.
Renewed team and capital focused on advancing lead compound for glaucoma into human studies Ongoing development of lead compound, THCVHS, includes near-term preclinical assessments of neuroprotection...
Emerald Bioscience Appoints Biotech Executive Punit Dhillon as CEO
10. August 2020 08:30 ET
|
Emerald Bioscience, Inc.
Renewed team and capital focused on advancing lead compound for glaucoma into clinical development San Diego, Calif, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI)...
Emerald Bioscience Joins Alliance for Biosecurity
08. April 2020 08:30 ET
|
Emerald Bioscience, Inc.
The Alliance is a government-industry consortium that is a leading voice on biosecurity issues in the United States Long Beach, Calif., April 08, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience,...